Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Multi-Center Phase III Trial Comparing Two Conditioning Regimens (CloFluBu and BuCyMel) in Children With Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation.

NCT05477589 is registered in ClinicalTrials.gov with Vastra Gotaland Region as lead sponsor.

NCT NCT05477589
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05477589 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Multi-Center Phase III Trial Comparing Two Conditioning Regimens (CloFluBu and BuCyMel) in Children With Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation.
Lead sponsor
Vastra Gotaland Region
Phase
Phase 3
Overall status
Recruiting
Start date
June 7, 2022
Completion date
December 31, 2031
Enrollment
170 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia (aml) in remission, stem cell transplantation